Market cap
$1,020 Mln
Market cap
$1,020 Mln
Revenue (TTM)
$202 Mln
P/E Ratio
358.7
P/B Ratio
13.9
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
0 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
55.1
Debt to Equity
0.3
Book Value
$0.6
EPS
$0
Face value
--
Shares outstanding
94,802,096
CFO
$52.29 Mln
EBITDA
$-234.71 Mln
Net Profit
$-272.76 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
| 4.5 | -3.0 | -1.8 | 16.1 | -1.9 | -- | -- |
|
BSE Sensex*
| -8.7 | 2.7 | -5.2 | -2.4 | 8.6 | 9.8 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
|---|---|---|---|
|
Enfusion Inc (ENFN)
| 6.1 | 0.3 | -53.8 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Enfusion Inc (ENFN)
|
10.8 | 1,020.1 | 201.6 | 2.8 | 2.2 | 4.4 | 358.7 | 13.9 |
| 85.9 | 972.4 | 545.9 | 9.2 | 5.3 | 3.3 | 113 | 3.3 | |
| 22.5 | 4,088.1 | 699.7 | -21.4 | -4.9 | -1.7 | -- | 3.1 | |
| 18.5 | 3,201.2 | 796.9 | 111.9 | 26.1 | 7.9 | 28.9 | 2.3 |
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Portfolio Management System, which generates a real-time... investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also provides Accounting/General Ledger System, a proper double-entry ledger that automates the posting of general ledger journal entries for all cash and securities transactions for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois. Read more
CEO & Director
Mr. Oleg Movchan
Chief Financial Officer
Mr. Bradley Herring
Headquarters
Chicago, IL
Website
The share price of Enfusion Inc (ENFN) is $10.76 (NYSE) as of 17-Apr-2025 16:04 EDT. Enfusion Inc (ENFN) has given a return of -1.94% in the last 3 years.
The P/E ratio of Enfusion Inc (ENFN) is 358.67 times as on 17-Apr-2025.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
472.71
|
18.22
|
|
2023
|
205.70
|
23.09
|
|
2022
|
-96.93
|
19.78
|
|
2021
|
-6.17
|
31.50
|
|
2020
|
--
|
--
|
The 52-week high and low of Enfusion Inc (ENFN) are Rs -- and Rs -- as of 27-Apr-2026.
Enfusion Inc (ENFN) has a market capitalisation of $ 1,020 Mln as on 17-Apr-2025. As per SEBI classification, it is a Small Cap company.
Before investing in Enfusion Inc (ENFN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.